These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12206749)
1. [A proposal for the rational use of the PET in oncology]. Borrego Dorado I; Vázquez Albertino R Rev Esp Med Nucl; 2002 May; 21(3):163-73. PubMed ID: 12206749 [TBL] [Abstract][Full Text] [Related]
2. [Cost-effective PET investigations in oncology]. Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Galuska L; Trón L; Esik O Magy Onkol; 2002; 46(3):203-23. PubMed ID: 12368917 [TBL] [Abstract][Full Text] [Related]
3. [Cost-effective PET scans in oncology]. Kálvin B; Fekésházy A; Lengyel Z; Szakáll S; Agoston P; Lengyel E; Székely J; Várady E; Galuska L; Trón L; Esik O Orv Hetil; 2002 May; 143(21 Suppl 3):1255-61. PubMed ID: 12077909 [TBL] [Abstract][Full Text] [Related]
4. Clinical role of positron emission tomography in oncology. Bomanji JB; Costa DC; Ell PJ Lancet Oncol; 2001 Mar; 2(3):157-64. PubMed ID: 11902566 [TBL] [Abstract][Full Text] [Related]
5. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Facey K; Bradbury I; Laking G; Payne E Health Technol Assess; 2007 Oct; 11(44):iii-iv, xi-267. PubMed ID: 17999839 [TBL] [Abstract][Full Text] [Related]
6. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy. Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004 [TBL] [Abstract][Full Text] [Related]
7. [Positron-emission tomography in oncology]. Zaplatnikov K; Menzel C; Döbert N; Diehl M; Hamscho N; Grünwald F Klin Med (Mosk); 2003; 81(12):13-21. PubMed ID: 14971150 [TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of positron emission tomography (PET) in clinical oncology]. Czech N; Brenner W; Kampen WU; Henze E Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983 [No Abstract] [Full Text] [Related]
9. PET in oncology: will it replace the other modalities? Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854 [TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography for benign and malignant disease. Visioni A; Kim J Surg Clin North Am; 2011 Feb; 91(1):249-66. PubMed ID: 21184913 [TBL] [Abstract][Full Text] [Related]
11. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Reske SN; Kotzerke J Eur J Nucl Med; 2001 Nov; 28(11):1707-23. PubMed ID: 11702115 [TBL] [Abstract][Full Text] [Related]
12. [Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Schirmerreschaft der Deutschen Gesellschaft for Nuklearmedizin]. Reske SN; Bares R; Büll U; Guhlmann A; Moser E; Wannenmacher MF Nuklearmedizin; 1996 Apr; 35(2):42-52. PubMed ID: 8721575 [TBL] [Abstract][Full Text] [Related]
13. PET/CT in oncology: for which tumours is it the reference standard? Collins CD Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S77-87. PubMed ID: 17921085 [TBL] [Abstract][Full Text] [Related]